Finance

Beta
Lists
ENVB:NASDAQ
Enveric Biosciences Inc
$1.96
-1.01%
(-0.020) 1D
$2.04
+4.08% (+0.080)
After hours
Closed: Jun 4, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ENVB...
Open
$1.96
High
$2.04
Low
$1.93
Mkt. cap
7.22M
Avg. vol.
2.09M
Volume
0.00
52-wk high
$17.64
52-wk low
$1.71
EPS
-$29.67
Beta
1.11
Shares outstanding
3.68M
No. of employees
6
Open
$1.96
High
$2.04
Low
$1.93
Mkt. cap
7.22M
Avg. vol.
2.09M
Volume
0.00
52-wk high
$17.64
52-wk low
$1.71
EPS
-$29.67
Beta
1.11
Shares outstanding
3.68M
No. of employees
6
News stories
From sources across the web
About Enveric Biosciences Inc
CEO-
Employees6
Founded1994
Headquarters-
SectorPharmaceutical industry
Websiteenveric.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.26M
402.42K
372.18K
345.97K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.22M
1.43M
1.78M
1.25M
Operating expense
2.52M
1.87M
2.19M
1.63M
Total operating expenses
2.52M
1.87M
2.19M
1.63M
Operating income
-2.52M
-1.87M
-2.19M
-1.63M
Other non operating income
-
-
2.00
-
EBT including unusual items
-2.52M
-1.87M
-2.19M
-1.63M
EBT excluding unusual items
-2.52M
-1.87M
-2.19M
-1.63M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.52M
-1.87M
-2.19M
-1.63M
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
274.00
-
-
Interest expense
-132.00
-
-250.00
-303.00
Net interest expenses
-132.00
274.00
-250.00
-303.00
Depreciation and amortization charges
39.98K
40.37K
39.48K
37.24K
EBITDA
-2.48M
-1.83M
-2.15M
-1.60M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer